StockTipsArenaBeta

BUY Manipal Health Enterprises Limited — Goldman Sachs

BUYManipal Health Enterprises Limited
Manipal Health Enterprises share price target & all analyst calls

byGoldman SachsHorizon: NA (inferred 1 year)10 Sept 2026via Zee Business (Live)

Entry₹735.15Inferred
Target₹865
Total upside +17.66%
Stop lossNot given
CMP₹607.352d ago
Active-17.38%+42.42%upside left 11 mo left
Follow Goldman Sachs for new calls(100% target hit, 31 closed calls)Get alertsWatch MANIPALHOS for new buy/sell callsGet alertsSee 3 other Long-term calls on MANIPALHOSSee 274 other Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 25 Oct, 9:35 pm IST
7 supporting3 neutral1 opposing
Supports the BUY call (7)

3 other SEBI-registered advisors have active long-term BUY calls on this stock

Advisor consensus · same horizon·24 Sept · 1mo ago

Neutral / worth noting (3)

Nothing found in this tip’s window yet.

Weighs against the BUY call (1)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Manipal Health Enterprises

All analyst calls on Manipal Health Enterprises

More from Goldman Sachs

Every call and its outcome